Bionet Corp.(TW:1784)
NT$45.00-2.00 (-4.26%)
TW:1784
Bionet Corp. financials statements
NT$45.00
At close:-2.00 (-4.26%)
Bionet Corp. (1784) Financial Statements
Bionet Corp. Financial Overview
Bionet Corp.'s market cap is currently NT$2.38B. The company's EPS TTM is NT$1.13; its P/E ratio is 40.18; and it has a dividend yield of 1.96%. Bionet Corp. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 1.24B | NT$ 1.22B | NT$ 1.13B | NT$ 980.38M | NT$ 921.42M |
| Gross Profit | NT$ 683.87M | NT$ 685.77M | NT$ 638.28M | NT$ 542.22M | NT$ 503.07M |
| Operating Income | NT$ -14.47M | NT$ 62.39M | NT$ 84.69M | NT$ 74.05M | NT$ 41.91M |
| EBITDA | NT$ 47.87M | NT$ 149.09M | NT$ 147.10M | NT$ 113.97M | NT$ 80.41M |
| Net Income | NT$ 51.43M | NT$ 83.70M | NT$ 78.40M | NT$ 37.97M | NT$ 26.62M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 1.40B | NT$ 1.58B | NT$ 907.35M | NT$ 438.82M | NT$ 385.09M |
| Total Assets | NT$ 3.08B | NT$ 3.16B | NT$ 2.35B | NT$ 1.84B | NT$ 1.78B |
| Total Debt | NT$ 116.27M | NT$ 96.43M | NT$ 45.01M | NT$ 15.25M | NT$ 14.52M |
| Net Debt | NT$ -139.77M | NT$ -146.36M | NT$ -193.48M | NT$ -146.37M | NT$ -107.28M |
| Total Liabilities | NT$ 822.58M | NT$ 760.40M | NT$ 626.47M | NT$ 513.97M | NT$ 468.19M |
| Stockholders' Equity | NT$ 1.27B | NT$ 1.33B | NT$ 1.19B | NT$ 1.08B | NT$ 1.10B |
| Cash Flow | |||||
| Free Cash Flow | NT$ 15.86M | NT$ 73.00M | NT$ 126.81M | NT$ 61.74M | NT$ -2.79M |
| Operating Cash Flow | NT$ 148.04M | NT$ 176.49M | NT$ 153.09M | NT$ 94.65M | NT$ 13.88M |
| Investing Cash Flow | NT$ 35.37M | NT$ -778.15M | NT$ -409.93M | NT$ -2.91M | NT$ -4.59M |
| Financing Cash Flow | NT$ -169.96M | NT$ 605.46M | NT$ 333.98M | NT$ -51.90M | NT$ -15.60M |
Currency in TWD

